Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Daniel Keizman

Clinical trials sponsored by Daniel Keizman, explained in plain language.

Trials to join now! 1

Blood test may predict which cancer patients benefit from immunotherapy

Knowledge-focused Recruiting now

This study aims to find out if measuring a protein called Galectin-3 in the blood can help predict how patients with certain cancers will respond to immunotherapy drugs (PD-1/PD-L1 inhibitors). Researchers will observe 300 adults with kidney, lung, liver, or bladder cancer who ar…

Sponsor: Daniel Keizman • Aim: Knowledge-focused

Last updated Mar 30, 2026 14:30 UTC